Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine DK Tobias, J Merino, A Ahmad, C Aiken, JL Benham, D Bodhini, AL Clark, ... Nature medicine 29 (10), 2438-2457, 2023 | 77 | 2023 |
Precision subclassification of type 2 diabetes: a systematic review S Misra, R Wagner, B Ozkan, M Schön, M Sevilla-Gonzalez, K Prystupa, ... Communications medicine 3 (1), 138, 2023 | 29 | 2023 |
Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort M Schön, K Prystupa, T Mori, OP Zaharia, K Bódis, M Bombrich, C Möser, ... The Lancet Diabetes & Endocrinology 12 (2), 119-131, 2024 | 9 | 2024 |
Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase J Hummel, C Benkendorff, L Fritsche, K Prystupa, A Vosseler, ... Nature metabolism 5 (9), 1475-1482, 2023 | 9 | 2023 |
Comprehensive validation of fasting-based and oral glucose tolerance test–based indices of insulin secretion against gold standard measures K Prystupa, R Renklint, Y Chninou, J Otten, L Fritsche, S Hoerber, A Peter, ... BMJ Open Diabetes Research and Care 10 (5), e002909, 2022 | 7 | 2022 |
Clusters of prediabetes and type 2 diabetes stratify all-cause mortality in a cohort of participants undergoing invasive coronary diagnostics K Prystupa, GE Delgado, AP Moissl, ME Kleber, AL Birkenfeld, M Heni, ... Cardiovascular Diabetology 22 (1), 211, 2023 | 4 | 2023 |
Systematic review of precision subclassification of type 2 diabetes S Misra, R Wagner, B Ozkan, M Schön, M Sevilla-Gonzalez, K Prystupa, ... medRxiv, 2023.04. 19.23288577, 2023 | 3 | 2023 |
Interscapular fat is associated with impaired glucose tolerance and insulin resistance independent of visceral fat mass A Vosseler, J Machann, L Fritsche, K Prystupa, C Kübler, HU Häring, ... Obesity 30 (11), 2233-2241, 2022 | 2 | 2022 |
Postprandial Dynamics of Proglucagon Cleavage Products and Their Relation to Metabolic Health R Wagner, SS Eckstein, L Fritsche, K Prystupa, S Hörber, HU Häring, ... Frontiers in Endocrinology 13, 892677, 2022 | 1 | 2022 |
Comprehensive validation of fasting-and oral glucose tolerance test-based indices of insulin secretion against gold-standard measures K Prystupa, R Renklint, Y Chninou, J Otten, L Fritsche, S Hörber, A Peter, ... medRxiv, 2022.04. 14.22273491, 2022 | 1 | 2022 |
Blood coagulation in Prediabetes clusters–impact on all-cause mortality in individuals undergoing coronary angiography S Hörber, K Prystupa, J Jacoby, A Fritsche, ME Kleber, AP Moissl, ... Cardiovascular Diabetology 23 (1), 306, 2024 | | 2024 |
Prädiabetes: differenzierte Betrachtung von Subtypen, Risiken und Pathomechanismen K Prystupa, R Wagner Die Diabetologie, 1-4, 2024 | | 2024 |
1545-P: Differences in Brain Anatomy between Diabetes Endotypes—Results from the UK-Biobank M CERRAI CERONI, J HUMMEL, K PRYSTUPA, HP MÜLLER, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
508-P: The Metabolic Phenome of the Hepatoprotective HSD17B13 Splice Variant rs72613567: TA Suggests Higher Lactate Clearance DM MENDEZ CARDENAS, K BÓDIS, K PRYSTUPA, I YURCHENKO, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
345-OR: Beyond Size Matters—The Impact of Pancreatic Volume and Pancreatic Fat on Type 2 Diabetes H YAMAZAKI, SI TAUCHI, M DOHKE, N HANAWA, Y KODAMA, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
1335-P: Insulin-Sensitive and Resistant Endotypes in Persons With and Without Recent-Onset Diabetes and Their Association with Diabetes-Related Outcomes K BÓDIS, K PRYSTUPA, OP ZAHARIA, M SCHÖN, C MÖSER, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
460-P: Dual Role of Factor XI in Mortality and Diabetes—Insights from the Ludwigshafen Risk and Cardiovascular Health Study K PRYSTUPA, M HENI, S HÖRBER, A PETER, P HELLSTERN, M KELM, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
1694-P: Subphenotype-Dependent Benefits of Bariatric Surgery in Data-Driven Clusters of Individuals at Risk for Type 2 Diabetes L SANDFORTH, V RAVERDY, A SANDFORTH, P BAUVIN, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
Insulinsensitive und-resistente Endotypen bei Personen mit und ohne neu diagnostiziertem Diabetes und deren Assoziationen mit diabetesbezogenen Komorbiditäten KB Bódis, K Prystupa, OP Zaharia, M Schön, C Möser, I Yurchenko, ... Diabetologie und Stoffwechsel 19 (S 01), FV 01, 2024 | | 2024 |
Erhöhte Laktat-Elimination als metabolisches Merkmal der hepatoprotektiven HSD17B13-Spleißvariante rs72613567: TA DMM Cardenas, KB Bódis, M Bombrich, K Prystupa, I Yurchenko, ... Diabetologie und Stoffwechsel 19 (S 01), FV 10, 2024 | | 2024 |